Mnemosyne Pharmaceuticals Inc — Form D/A
Mnemosyne Pharmaceuticals Inc of PROVIDENCE, RI, a company, filed a Form D amendment with the SEC on 2013-02-01. The offering totals $5.4M, of which $3.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-02-01
- Form: D/A
- Accession: 0001542171-13-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $5.4M
- Amount sold: $3.2M
- Remaining: $2.1M
- Investors: 4
- Date of first sale: 2012-02-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-173595
Issuer
- Name: Mnemosyne Pharmaceuticals Inc
- CIK: 0001542171
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: THREE DAVOL SQUARE, PROVIDENCE, RI, 02903
- Phone: 401-632-0383
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Jessica Barnes | Director | Providence, RI |
| Jared Fertman | Director | Providence, RI |
| Peter Barrett | Director | Palo Alto, CA |
| James Bristol | Director | Cambridge, MA |
| Richard Horan | Director | Edina, MN |
| Daniel Behr | Director | Westborough, MA |
| Kollol Pal | Director | Waltham, MA |
| Kollol Pal | Executive Officer | Waltham, MA |
| William Koster | Director | Westborough, MA |
| Frank Menniti | Executive Officer | Providence, RI |
| Vanessa King | Director | Providence, RI |
| Vanessa King | Executive Officer | Providence, RI |
| Benjamin Bronstein | Director | New York, NY |
Other filings by this issuer (3)
More